X4 Pharmaceuticals has appointed Kelly Gold to its Board of Directors effective July 1, 2026. Ms. Gold will serve as an independent director and member of the Audit Committee. She is currently the Chief Financial Officer at CAMP4 Therapeutics and brings financial leadership, capital markets expertise, and a scientific background to the board. The company stated that her experience as a public company CFO and her understanding of the biotech landscape will support X4 as it advances mavorixafor toward potential approval and commercialization.
X4 Pharmaceuticals IncAppointment of experienced CFO to board strengthens financial oversight and supports commercialization efforts.
CAMP4 THERAPEUTICS CORPORATION